THERAPEUTIC ANTIBODIES

LGR5 binding agents, in particular antibodies or fragments thereof which bind to human LGR5, and the use of such binding agents in the treatment of disease, such as cancer and inflammatory disease, and the detection of LGR5. L'invention concerne des agents de liaison à LGR5, en particulier des...

Full description

Saved in:
Bibliographic Details
Main Authors DE LA ROCHE, Maike, DE LA ROCHE, Marc Andrew, SKJØDT, Mikkel-Ole, SKJØDT, Karsten
Format Patent
LanguageEnglish
French
Published 12.10.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

More Information
Summary:LGR5 binding agents, in particular antibodies or fragments thereof which bind to human LGR5, and the use of such binding agents in the treatment of disease, such as cancer and inflammatory disease, and the detection of LGR5. L'invention concerne des agents de liaison à LGR5, en particulier des anticorps ou des fragments de ceux-ci qui se lient au LGR5 humain, et l'utilisation de tels agents de liaison dans le traitement d'une maladie, telle qu'un cancer et une maladie inflammatoire, et la détection de LGR5.
Bibliography:Application Number: WO2023GB50512